Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ojaara
Ojaara
In pleasant surprise for GSK, FDA approves Jakafi challenger Ojjaara in broad blood cancer use
In pleasant surprise for GSK, FDA approves Jakafi challenger Ojjaara in broad blood cancer use
Fierce Pharma
GSK
FDA
Ojaara
momelotinib
myelofibrosis
Flag link:
